Skip to main content

ABI Stops Selling HTS Biosystems SPR Array Platform

NEW YORK, Oct. 5 (GenomeWeb News) - Applied Biosystems will no longer develop, service, or distribute HTS Biosystems' surface plasmon resonance array platform, HTS said today.

 

From now on, the platform, sold as the 8500 Affinity Chip Analyzer by ABI, will be marketed by HTS Biosystems as the Flexchip Kinetic Analysis System.

 

As a result of its ongoing business review, ABI decided to stop selling the instrument. "Although we have had a successful relationship with Applied Biosystems, we understand their future market emphasis, and agree that the Flexchip system's success is best served through specific market focus by HTS," said Gregory Freitag, HTS' CEO, in a company statement.

 

The two companies first agreed to bring the instrument to market  in 2002.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.